Fumaric Acid

Fumaric Acid

SCHEMBL6603599

C[C@H](N)Cn1ccc2cc(Cl)c3ncccc3c21.O=C(O)/C=C/C(=O)O

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HTR2A known ✓ P28223 15/20 0.82
HTR2C known ✓ P28335 15/20 0.82
HTR2B known ✓ P41595 10/20 0.82
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
HIF1A Q16665 1/20 0.37
KMO O15229 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SLC2A1 P11166 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL6603600 1.00 HTR2A (0.82) HTR2AHTR2CHTR2BCYP1A2CYP3A4
SCHEMBL906124 0.91 HTR2A (1.00) HTR2AHTR2CHTR2BCYP1A2CYP3A4
SCHEMBL6602352 0.82 HTR2A (0.78) HTR2AHTR2CHTR2BCYP3A4HIF1A
SCHEMBL6602349 0.82 HTR2A (0.78) HTR2AHTR2CHTR2BCYP3A4HIF1A
Fumaric Acid SCHEMBL6602840 0.81 HTR2A (0.80) HTR2AHTR2CHTR2B
Fumaric Acid SCHEMBL6602847 0.81 HTR2A (0.80) HTR2AHTR2CHTR2B
Fumaric Acid SCHEMBL6602929 0.81 HTR2A (0.80) HTR2AHTR2CHTR2B
Fumaric Acid SCHEMBL6602921 0.81 HTR2A (0.80) HTR2AHTR2CHTR2B
Fumaric Acid SCHEMBL27353869 0.75 HTR2C (0.62) HTR2AHTR2CHTR2BCYP1A2CYP3A4
Ammonia Solution, Strong SCHEMBL906126 0.75 HTR2A (0.70) HTR2AHTR2CHTR2BL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109809-B1 PYRROLOQUINOLINES FOR TREATMENT OF OBESITY CEREBRUS PHARM LTD (GB) 2004-11-17 EP disclosed
US-6365598-B1 FOR THERAPY AND PROPHYLAXIS OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM; DAMAGE TO THE CENTRAL NERVOUS SYSTEM; CARDIOVASCULAR DISORDERS; GASTROINTESTINAL DISORDERS; DIABETES INSIPIDUS; AND SLEEP APNEA VERNALIS RESEARCH LIMITED (GB) 2002-04-02 US disclosed